Global Immunosuppressants Market Report 2020 - Opportunities And Strategies, Market Forecast And Trends
The global immunosuppressants market is expected to grow from $14.9 billion in 2019 to $15.08 billion in 2020 at a compound annual growth rate (CAGR) of 1.21%. The slow growth is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $21.44 billion in 2023 at a CAGR of 12.45%.
The immunosuppressant market consists of sales of immunosuppressants or anti-rejection drugs generated by companies manufacturing immunosuppressant drugs. Immunosuppressants are medicinal substances that prevent or inhibit activity in the immune system. Immunosuppressive drugs are mainly used in organ transplantation procedures and also in the treatment of certain autoimmune diseases such as rheumatoid arthritis, psoriasis, multiple sclerosis, and others.
Request For A Sample For The Global Immunosuppressants Market Report:
The global immunosuppressants market is further segmented based on type and geography.
By Drug Class: Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Others.
By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases.
By Distribution Channel: Hospital pharmacies, Retail pharmacies, Online pharmacies.
By Geography: The global immunosuppressants market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North America immunosuppressants market accounts for the largest share in the global immunosuppressants market.
Read More On The Report For The Global Immunosuppressants Market At:
Trends In The Immunosuppressants Market
Stringent government regulations are expected to hamper the growth of the market. Regulators such as the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) maintain public safety for food and drugs through a stringent regulatory drug approval process. For an immunosuppressant drug to be approved by the regulatory authorities, the sponsor must provide satisfactory evidence regarding the safety and efficacy of a drug in a patient with a defined clinical condition
Immunosuppressants Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides immunosuppressants market overviews, analyzes and forecasts market size and growth for the global immunosuppressants market, immunosuppressants market share, immunosuppressants market players, immunosuppressants market segments and geographies, immunosuppressants market’s leading competitors’ revenues, profiles and market shares. The immunosuppressants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.